Related references
Note: Only part of the references are listed.IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro
Qing Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Differentiation of mesenchymal stem cells for cartilage tissue engineering: Individual and synergetic effects of three-dimensional environment and mechanical loading
J. A. Panadero et al.
ACTA BIOMATERIALIA (2016)
Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer
Vivian Labovsky et al.
TUMOR BIOLOGY (2016)
Imbalance Between Bone Morphogenetic Protein 2 and Noggin Induces Abnormal Osteogenic Differentiation of Mesenchymal Stem Cells in Ankylosing Spondylitis
Zhongyu Xie et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Stem cells and bone: A historical perspective
Paolo Bianco
BONE (2015)
Stromal cells and stem cells in clinical bone regeneration
Warren L. Grayson et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Contribution of the Interleukin-6/STAT-3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells
Masahiro Kondo et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Interleukin-6 and its receptors: A highly regulated and dynamic system
Janina Wolf et al.
CYTOKINE (2014)
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Ying Wang et al.
NATURE IMMUNOLOGY (2014)
Mesenchymal stem cells in joint disease and repair
Frank Barry et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Activated NF-κB in Bone Marrow Mesenchymal Stem Cells from Systemic Lupus Erythematosus Patients Inhibits Osteogenic Differentiation Through Downregulating Smad Signaling
Yu Tang et al.
STEM CELLS AND DEVELOPMENT (2013)
Therapeutic Targeting of the Interleukin-6 Receptor
Toshio Tanaka et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Interleukin-6: from an inflammatory marker to a target for inflammatory diseases
Mercedes Rincon
TRENDS IN IMMUNOLOGY (2012)
The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
Athena Chalaris et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Toshio Tanaka et al.
FEBS LETTERS (2011)
Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis
Sindhu T. Mohanty et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Interleukin-6 Maintains Bone Marrow-Derived Mesenchymal Stem Cell Stemness by an ERK1/2-Dependent Mechanism
Katie L. Pricola et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women
M. Bustamante et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
Stefan Rose-John et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation
Shousaku Itoh et al.
BONE (2006)
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici et al.
CYTOTHERAPY (2006)
gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells
A Erices et al.
EXPERIMENTAL CELL RESEARCH (2002)
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae
P Palmqvist et al.
JOURNAL OF IMMUNOLOGY (2002)
Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes
J Paysant et al.
CYTOKINE (2000)
Share Paper
